Evidence map›Paper›PMID 38249891›Full record

ArticleJournal of thoracic disease2023

Lung transplantation for emphysema: only emphysema or something else?

Víctor Manuel Mora-Cuesta, Laura Sánchez-Moreno, David Iturbe-Fernández, Elena Pérez-Barquín, Sandra Tello-Mena, Pilar Alonso-Lecue, Sheila Izquierdo-Cuervo, Sara Naranjo-Gozalo, José Manuel Cifrián-Martínez, José Javier Gómez-Román

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Víctor Manuel Mora-CuestaDepartment of Respiratory, Lung Transplant Unit, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
Laura Sánchez-MorenoValdecilla Research Institute (IDIVAL), Cantabria University, Santander, Cantabria, Spain.
David Iturbe-FernándezDepartment of Respiratory, Lung Transplant Unit, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
Elena Pérez-BarquínSchool of Medicine, Cantabria University, Santander, Cantabria, Spain.
Sandra Tello-MenaDepartment of Respiratory, Lung Transplant Unit, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
Pilar Alonso-LecueValdecilla Research Institute (IDIVAL), Cantabria University, Santander, Cantabria, Spain.
Sheila Izquierdo-CuervoDepartment of Respiratory, Lung Transplant Unit, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
Sara Naranjo-GozaloValdecilla Research Institute (IDIVAL), Cantabria University, Santander, Cantabria, Spain.
José Manuel Cifrián-MartínezDepartment of Respiratory, Lung Transplant Unit, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
José Javier Gómez-RománValdecilla Research Institute (IDIVAL), Cantabria University, Santander, Cantabria, Spain.
Marqués de Valdecilla University Hospital · ESInstituto de Investigación Marqués de Valdecilla · ESUniversidad de Cantabria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Some studies have reviewed lung explants histology to determine the frequency of pretransplant non-identified neoplasms or explore its diagnostic correlation with a previous diagnosis of interstitial lung disease (ILD). This study aims to review the histopathology of explants from patients who underwent lung transplantation (LT). Methods: A retrospective, single-center study that included patients who underwent LT for emphysema between 01 January 2011 and 31 October 2021. The control group was composed of patients with lung cancer who underwent a lung resection between 01 November 2011 and 31 December 2019 and had a previous diagnosis of chronic obstructive pulmonary disease (COPD) prior to lung resection surgery. A systematic review was performed of histological findings to compare the frequency of additional histological diagnoses. Results: The study sample included 160 patients (43.8%) who received a lung transplant for emphysema and 205 patients with COPD and lung cancer treated surgically. Although the patients in the cancer group were significantly older and had more comorbidities and higher cumulative tobacco consumption, transplant recipients received an additional significative histologic diagnosis more frequently (58.1% Conclusions: Significant additional histological findings were more frequent in the group of lung transplant recipients with emphysema. Notably, these findings were not explained by tobacco use, and they were significantly more frequent in transplant recipients than in patients with a previous diagnosis of COPD and higher cumulative tobacco consumption but with a better respiratory functional status.

Indexed as

emphysemainterstitial lung disease (ILD)Lung transplantation (LT)

Identifiers

PMID38249891
PMCPMC10797347
OpenAlexW4390349935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.